SCHEMBL4407876

SCHEMBL4407876

O=C(O)NCCOc1ccc2c(c1)C(C1(c3ccc(Cl)cc3)CC1)=NCC2.Oc1ccc2c(c1)C(C1(c3ccc(Cl)cc3)CC1)=NCC2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
NPC1 O15118 2/20 0.35
BDKRB1 P46663 2/20 0.34
KDM4E B2RXH2 2/20 0.34
POLB P06746 1/20 0.34
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
ALDH1A1 P00352 1/20 0.33
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
RAB9A P51151 1/20 0.33
TSHR P16473 1/20 0.33
ATM Q13315 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL990199 0.96 NPC1 (0.38) MAOAMAOBNPC1BDKRB1KDM4E
SCHEMBL989898 0.84 PDK2 (0.39) MAOAMAOBNPC1BDKRB1KDM4E
SCHEMBL990550 0.83 KDM4E (0.38) MAOAMAOBKDM4EPOLBDRD2
SCHEMBL989560 0.83 F10 (0.42) NPC1KDM4ERAB9A
SCHEMBL989752 0.82 CYP3A4 (0.37) MAOAMAOBNPC1BDKRB1KDM4E
SCHEMBL989604 0.82 CYP3A4 (0.40) MAOAMAOBNPC1BDKRB1KDM4E
SCHEMBL990311 0.82 ALDH1A1 (0.40) NPC1ALDH1A1RAB9AATM
SCHEMBL988386 0.81 RAB9A (0.37) MAOAMAOBNPC1BDKRB1KDM4E
SCHEMBL989639 0.81 SLC6A2 (0.46) MAOAMAOBESR1ESR2SLC6A2
SCHEMBL989642 0.81 NPC1 (0.41) NPC1BDKRB1POLBRAB9AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8653100-B2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy ABBVIE INC. (US) 2014-02-18 US disclosed
EP-2271625-B1 TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBOTT GMBH & CO KG (DE) 2012-09-12 EP disclosed
WO-2009121872-A2 TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBOTT GMBH & CO. KG (DE) 2009-10-08 WO disclosed